Dae Hwa Pharm Co (XKRX:067080) Accounts Payable & Accrued Expense : ₩20,355 Mil (As of Jun. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Dae Hwa Pharm Co Accounts Payable & Accrued Expense?

Dae Hwa Pharm Co's quarterly accounts payable & accrued expense increased from Dec. 2023 (₩20,113 Mil) to Mar. 2024 (₩21,519 Mil) but then declined from Mar. 2024 (₩21,519 Mil) to Jun. 2024 (₩20,355 Mil).

Dae Hwa Pharm Co's annual accounts payable & accrued expense increased from Dec. 2021 (₩12,599 Mil) to Dec. 2022 (₩15,872 Mil) and increased from Dec. 2022 (₩15,872 Mil) to Dec. 2023 (₩20,113 Mil).

Dae Hwa Pharm Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Dae Hwa Pharm Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dae Hwa Pharm Co Accounts Payable & Accrued Expense Chart

Dae Hwa Pharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

15,149.75

12,832.55

12,598.68

15,871.99

20,112.76

Dae Hwa Pharm Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															17,200.68	18,543.05	20,112.76	21,519.45	20,355.45

Dae Hwa Pharm Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Dae Hwa Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dae Hwa Pharm Co Ltd (XKRX:067080) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

495 Hanu-ro, Hoengseong-eup, Hoengseong-gun, Seoul, Gangwon-do, KOR, 225-804

Website

http://www.dhpharm.co.kr

Dae Hwa Pharm Co Ltd is a specialized pharmaceutical company. It is mainly involved in manufacturing and distribution of pharmaceutical products. The company controls approximately 70% of the domestic transdermal drug delivery system market. The company offers analgesics and anti-inflammatory drugs, antihistamines, skeletal muscle relaxants, and cardiovascular drugs. Its products are exported to Asia, South America, Africa, and the Middle East.

Dae Hwa Pharm Co Headlines

No Headlines